Australia’s trade surplus declined in May as the growth in imports exceeded the increase in exports, official data showed on Thursday.

The dollar was on the back foot ahead of elections in the U.K. and France, and before the release of key U.S. nonfarm payrolls report, due Friday.

Alembic Pharmaceuticals (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivosidenib Tablets, 250 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Tibsovo Tablets, 250 mg, of Servier Pharmaceuticals LLC (Servier).

Sebi on Thursday issued a circular requiring stock brokers to establish an institutional mechanism for prevention and detection of fraud or market abuse in a bid to protect the interest of investors in securities market.
The circular mandates the implementation of systems for the surveillance of trading activities and internal controls, introduction of a whistle-blower policy, among other obligations.
These requirements are part of Sebi (Stock Brokers) (Amendment) Regulations, 2024, which aim to ensure higher standards of market integrity and investor protection.
The standards for implementation of the same, including operational modalities will be formulated by the broker’s Industry Standards Forum (ISF), in consultation with the Securities and Exchange Board of India (Sebi), the regulator said in the circular.
The implementation will be based on the size of the stock brokers. Brokers with more than 50,000 active Unique Client Codes (UCCs) are required to comply by January 1, …

This exposure would be subject to an overall cap of 35 per cent investment in the group companies of the sponsor